How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Virtual Reality Neuropsychological Therapy Market
- By Therapy Type: Cognitive Rehabilitation Therapy, Exposure Therapy, Motor Rehabilitation Therapy, Pain Management Therapy, Anxiety and Stress Reduction Therapy
- By End-User: Hospitals and Clinics, Rehabilitation Centers, Home Care Settings, Research and Academic Institutions, Mental Health Facilities
- By Technology Platform: Head-Mounted Displays (HMDs), CAVE Automatic Virtual Environment, Desktop-Based VR Systems, Mobile VR Devices
- By Neurological Disorder: Stroke Rehabilitation, Traumatic Brain Injury (TBI), Alzheimer’s Disease and Dementia, Parkinson’s Disease, Multiple Sclerosis
- By Therapy Delivery Mode: Clinician-Guided Therapy, Self-Guided Therapy, Remote Teletherapy
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Cognitive Rehabilitation Therapy leads By Therapy Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Virtual Reality Neuropsychological Therapy Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Therapy Type 5
End-User 5
Technology Platform 4
Neurological Disorder 5
Therapy Delivery Mode 3
Companies profiled
MindMaze
Psious
Oxford VR
AppliedVR
Neuro Rehab VR
Karuna Labs
Cognitive FX
Mimerse
XRHealth
BehaVR
Virtualware
Emteq Labs
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →MindMaze
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Psious
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Oxford VR
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →AppliedVR
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Neuro Rehab VR
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Karuna Labs
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Cognitive FX
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Mimerse
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →XRHealth
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →BehaVR
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Virtualware
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Emteq Labs
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →RehabVR
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Vivid Vision
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Floreo
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,676M by 2033 · 6.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Cognitive Rehabilitation Therapy42.3
- Exposure Therapy16.0
- Motor Rehabilitation Therapy10.3
- Pain Management Therapy15.5
- Anxiety and Stress Reduction Therapy16.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$722.7M → $1,133M · 5.8%
Europe$503.7M → $927.5M · 7.9%
Asia Pacific$459.9M → $858.4M · 8.1%
Latin America$284.7M → $476.2M · 6.6%
Middle East and Africa$219.0M → $382.5M · 7.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.642026
6.652027
6.672028
6.682029
6.702030
6.692031
6.722032
6.722033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- MindMaze25.8
- Psious23.9
- Oxford VR4.2
- AppliedVR4.4
- Neuro Rehab VR8.7
- Karuna Labs4.9
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Therapy Type17.6%
End-User21.8%
Technology Platform25.9%
Neurological Disorder17.8%
Therapy Delivery Mode16.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.0
- Europe24.5
- Asia Pacific22.7
- Latin America12.6
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| MindMaze | 99 | 74 | 85 | 96 | 79 | 82 | 86 |
| Psious | 90 | 79 | 77 | 90 | 77 | 90 | 84 |
| Oxford VR | 83 | 64 | 65 | 83 | 76 | 86 | 76 |
| AppliedVR | 77 | 80 | 60 | 57 | 76 | 79 | 72 |
| Neuro Rehab VR | 57 | 54 | 73 | 71 | 69 | 69 | 66 |
| Karuna Labs | 68 | 63 | 52 | 67 | 55 | 56 | 60 |
| Cognitive FX | 66 | 59 | 52 | 64 | 58 | 41 | 57 |
| Mimerse | 59 | 46 | 45 | 54 | 60 | 54 | 53 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- MindMaze
- Psious
- Oxford VR
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| MindMaze | ✓ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Psious | ✓ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Oxford VR | ✓ | ◐ | − | ✓ | ◐ | ◐ |
| AppliedVR | ◐ | ✓ | − | − | ✓ | ✓ |
| Neuro Rehab VR | − | ◐ | ◐ | ◐ | ◐ | ✓ |
| Karuna Labs | ◐ | ◐ | − | ◐ | − | − |
| Cognitive FX | ◐ | ◐ | ◐ | ✓ | ◐ | − |
| Mimerse | − | − | − | − | ✓ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1MindMaze86
2Psious84
3Oxford VR76
4AppliedVR72
5Neuro Rehab VR66
6Karuna Labs60
7Cognitive FX57
8Mimerse53
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
MindMazePsious
Challenger2
Strong scale, closing on the leaders.
Oxford VRAppliedVR
Contender3
Focused players with pockets of strength.
Neuro Rehab VRKaruna LabsCognitive FX
Niche1
Specialists in a single segment or region.
Mimerse
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Therapy Type in North America, then scale across Virtual Reality Neuropsychological Therapy Market — a $118M beachhead inside a $1.70B market.
Beachhead (SOM)$118Mobtainable near-term
Serviceable (SAM)$658Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Cognitive Rehabilitation Therapy
Best fit — highest urgency & budget in Therapy Type.
Economic buyer77 fit
Exposure Therapy
Strong fit — clear ROI and a fast path to value.
End user66 fit
Motor Rehabilitation Therapy
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Therapy Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End-User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Technology Platform
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel29%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Therapy Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Virtual Reality Neuropsychological Therapy Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified23%
Evaluation12%
Closed-won8%
$15.9KCAC
$70KLTV
4.4:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Virtual Reality Neuropsychological Therapy Market is a durable-growth opportunity — $9.26B by 2033, compounding at 8.1%.
TAM · 2025$4.98Btoday
TAM · 2033$9.26Bforecast
CAGR8.1%2027–2033
Cumulative$62.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$9.26BTotal addressable market
SAM$3.78BServiceable available market
SOM$829MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.1% CAGR
Demand compounds through 2033, outpacing GDP across Therapy Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Therapy Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$9.26BLarge & growingTAM by 2033 at 8.1% CAGR
$3.78BServiceable nowreachable with today’s model
$829MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.22BBear5.2% CAGR
$9.26BBase8.1% CAGR
$11.8BBull10.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End-User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Virtual Reality Neuropsychological Therapy Market — a $8.77B market by 2033. Plan: grow share from 8.5% to 16.6%.
Market size · 2033$8.77Btotal addressable
Market CAGR7.0%2027–2033
Target share16.6%from 8.5% today
Revenue ambition$1.46Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.5% | 16.6% | Behind |
| Revenue | $714M | $1.46B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 30.0% | 39.7% | On track |
| Customer retention | 92.0% | 93.4% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Therapy Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End-User capability
A defensible second engine — invest in End-User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Therapy Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End-User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $218M capacity & capability investment
- Greenlight bolt-on M&A in End-User
- Authorise North America expansion plan
- Fund R&D program for Therapy Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Virtual Reality Neuropsychological Therapy Market conversation — a $3.86B market you can size, segment and defend in minutes.
Market size · 2033$3.86Btotal opportunity
Growth5.8%CAGR to 2033
Addressable buyers1,045+accounts in scope
Typical ROI7.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Therapy Type
Goal Grow share in Therapy Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.6×return on cost, year one
< 3 mopayback period
$92K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
MindMazePsiousOxford VRAppliedVRNeuro Rehab VRKaruna LabsCognitive FXMimerse+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Virtual Reality Neuropsychological Therapy Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Virtual Reality Neuropsychological Therapy Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Virtual Reality Medical Simulation Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportVirtual Reality Based Telerehabilitation System Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportVirtual Patient Simulator Platform Market
Market size, share, segmentation and regional forecast.
$973M market · 2025 base year
View reportVirtual Patient Simulator Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportVirtual Neurorehabilitation Device Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportVirtual Mother and Child Healthcare Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportVirtual Microscopy Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportVirtual Medical Diagnostics Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportVirtual Medical Assistant Service Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportVirtual Human Anatomy Software Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportVirtual Hospital Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportVirtual Healthcare Delivery Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.